ChinaBio Today -- As part of its upcoming reform of healthcare policy, China is expected to implement a trial policy of zero markup on drugs distributed from government hospitals and health centers. The government will establish pilot programs in several cities that will wipe out the 7% to 15% markup on certain drugs that is currently allowed by the central government. The initiative was announced in an address delivered to the 2009 National Health Working Conference by Chen Zhu, the Minister of the Ministry of Health.
